Sensorion

151 articles about Sensorion

• Sensorion Reports Its 2018 Annual Results; 75% of Patients Enrolled in the Sens-111 Clinical Trial

  3/27/2019

  SENS-111 phase 2 AUV trial: major progress with 75% of patients enrolled in the clinical trial assessing the efficacy of SENS-111 on vertigo intensity

• Sensorion strengthens its financial structure by issuing a €4.7 million nominal bond issue subscribed by new European investors and management

  3/11/2019

  Sensorion announced a €4.7 million nominal bond issue, consisting of one (i) convertible bond issue1 for a nominal amount of €3,4 million subscribed by several new European investors as well as a bond issue2 for a nominal amount of €1.3 million subscribed by these same European investors for an amount of €1 million and the balance by the Company's management, Mr. Patrick Langlois, Chairman of the Board of Directors and Ms. Nawal Ouzren, Chief Executive Officer.

• 

  Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant...

  12/19/2017

  The collaboration will evaluate therapeutic approaches using SENS-401 in combination with cochlear implants, with preclinical studies initiating in 2018, and potential clinical trials to begin as soon as 2019.

• Sensorion Reports 2017 First-Half Results

  10/19/2017

  Sensorion announces its results for the first half of the year ending June 30, 2017, as well as its recent developments.

• Sensorion Announces Positive Results From SENS-218 Phase I Clinical Trial Undertaken In The UK

  9/7/2016

• Sensorion To Present At The 18th Annual Rodman & Renshaw Global Investment Conference

  9/1/2016

• Sensorion Obtains FDA Approval To Initiate A Clinical Study Of SENS-111 In Acute Severe Vertigo

  9/1/2016

• Sensorion Strengthens Its Financial Structure With The Exercise Of The Second Tranche Of Its Financing Agreement

  8/18/2016

• Sensorion To Present Data From Phase Ib Clinical Trial Of SENS-111 At AAO-HNSF Annual Meeting

  5/12/2016

• Sensorion Receives Approval From The UK Drug Agency To Initiate Clinical Trial Of SENS-218

  1/6/2016

• Sensorion, The Specialist In Inner Ear Diseases, Completes A New Funding Round To Begin The Human Clinical Trial Phase

  1/20/2015